Kidney benefit by SGLT2i may be mediated by hematocrit - PACE-CME

Kidney benefit by SGLTi may be mediated by hematocrit

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
MinuteCE®
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
1.25 program credits
- Csaba P. Kovesdy, MD
- Finnian R. Mc Causland, MD
1.25 program credits
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
MinuteCE®
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
1.25 program credits
- Akshay S. Desai, MD
- John McMurray, MD
1.25 program credits
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
MinuteCE®
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
0.75 program credits
- James Burton, DM, FRCP
- Aaron Wong, MD
0.75 program credits
MinuteCE®
Strategies for managing hyperkalemia in cardiorenal disease: A clinical dialogue defining a roadmap to improved outcomes
0.75 credits 3 episodes
- Gianluigi Savarese, MD
- James Burton, DM, FRCP
- Aaron Wong, MD
0.75 credits 3 episodes